Abe M. Hiura K. Wilde J. Shioyasono A. Moriyama K. Hashimoto T. Kido S. Oshima T. Shibata H. Ozaki S. Inoue D. Matsumoto T. 2004 Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion Blood 104 2484 2491
Angelucci A. Festuccia C. D'Andrea G. Teti A. Bologna M. 2002 Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators Biological Chemistry 383 229 234
Asosingh K. Gunthert U. Bakkus M.H. De Raeve H. Goes E. Van Riet I. Van Camp B. Vanderkerken K. 2000 In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells Cancer Research 60 3096 3104
Asosingh K. Gunthert U. De Raeve H. Van Riet I. Van Camp B. Vanderkerken K. Bakkus M.H. Goes E. 2001 A unique pathway in the homing of murine multiple myeloma cells: CD44v10 mediates binding to bone marrow endothelium Cancer Research 61 2862 2865
Asosingh K. De Raeve H. de Ridder M. Storme G.A. Willems A. Van Riet I. Van Camp B. Vanderkerken K. 2005 Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression Haematologica 90 810 817
Chellaiah M.A. Hruska K.A. 2003 The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility Calcified Tissue International 72 197 205
Denhardt D.T. Giachelli C.M. Rittling S.R. 2001 Role of osteopontin in cellular signaling and toxicant injury Annual Review of Pharmacology and Toxicology 41 723 749
van Driel M. Gunthert U. Stauder R. Joling P. Lokhorst H.M. Bloem A.C. 1998 CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease Leukemia 12 1821 1828
Eisterer W. Bechter O. Hilbe W. van Driel M. Lokhorst H.M. Thaler J. Bloem A.C. Gunthert U. Stauder R. 2001 CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma Leukemia Research 25 1051 1057
Fisher L.W. Hawkins G.R. Tuross N. Termine J.D. 1987 Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone Journal of Biological Chemistry 262 9702 9708
Fisher L.W. Stubbs III. J.T. Young M.F. 1995 Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins Acta Orthopedica 266 61 65
Ge N.L. Rudikoff S. 2000 Insulin-like growth factor I is a dual effector of multiple myeloma cell growth Blood 96 2856 2861
Gunthert U. 1996 CD44 in malignant disorders Current Topics in Microbiology and Immunology 213 Pt 1 271 285
Imai K. Kobayashi M. Wang J. Ohiro Y. Hamada J. Cho Y. Imamura M. Musashi M. Kondo T. Hosokawa M. Asaka M. 1999 Selective transendothelial migration of hematopoietic progenitor cells: a role in homing of progenitor cells Blood 93 149 156
Katagiri Y.U. Sleeman J. Fujii H. Herrlich P. Hotta H. Tanaka K. Chikuma S. Yagita H. Okumura K. Murakami M. Saiki I. Chambers A.F. Uede T. 1999 CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis Cancer Research 59 219 226
Kuehl W.M. Bergsagel P.L. 2002 Multiple myeloma: evolving genetic events and host interactions Nature Reviews Cancer 2 175 187
Liebisch P. Eppinger S. Schopflin C. Stehle G. Munzert G. Dohner H. Schmid M. 2005 CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q Haematologica 90 489 493
Lin Y.H. Huang C.J. Chao J.R. Chen S.T. Lee S.F. Yen J.J. Yang-Yen H.F. 2000 Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor Molecular and Cellular Biology 20 2734 2742
Manning L.S. Berger J.D. O'Donoghue H.L. Sheridan G.N. Claringbold P.G. Turner J.H. 1992 A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse British Journal of Cancer 66 1088 1093
Menu E. Braet F. Timmers M. Van Riet I. Van Camp B. Vanderkerken K. 2002 The F-actin content of multiple myeloma cells as a measure of their migration Annals of the New York Academy of Sciences 973 124 136
Menu E. Asosingh K. Van Riet I. Croucher P. Van Camp B. Vanderkerken K. 2004a Myeloma cells (5TMM) and their interactions with the marrow microenvironment Blood Cells Molecules and Diseases 33 111 119
Menu E. Kooijman R. Van Valckenborgh E. Asosingh K. Bakkus M. Van Camp B. Vanderkerken K. 2004b Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model British Journal of Cancer 90 1076 1083
Ogawa M. Nishiura T. Oritani K. Yoshida H. Yoshimura M. Okajima Y. Ishikawa J. Hashimoto K. Matsumura I. Tomiyama Y. Matsuzawa Y. 2000 Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line Cancer Research 60 4262 4269
Philip S. Bulbule A. Kundu G.C. 2001 Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells Journal of Biological Chemistry 276 44926 44935
Radl J. Croese J.W. Zurcher C. Van den Enden-Vieveen M.H. de Leeuw A.M. 1988 Animal model of human disease. Multiple myeloma American Journal of Pathology 132 593 597
Ria R. Vacca A. Ribatti D. Di Raimondo F. Merchionne F. Dammacco F. 2002 Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma Haematologica 87 836 845
Roodman G.D. 2002 Role of the bone marrow microenvironment in multiple myeloma Journal of Bone and Mineral Research 17 1921 1925
Saeki Y. Mima T. Ishii T. Ogata A. Kobayashi H. Ohshima S. Ishida T. Tabunoki Y. Kitayama H. Mizuki M. Katada Y. Asaoku H. Kitano M. Nishimoto N. Yoshizaki K. Maeda M. Kon S. Kinoshita N. Uede T. Kawase I. 2003 Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications British Journal of Haematology 123 263 270
Sirohi B. Powles R. 2004 Multiple myeloma Lancet 363 875 887
Standal T. Hjorth-Hansen H. Rasmussen T. Dahl I.M. Lenhoff S. Brenne A.T. Seidel C. Baykov V. Waage A. Borset M. Sundan A. Hjertner O. 2004 Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma Haematologica 89 174 182
Stauder R. Van Driel M. Schwarzler C. Thaler J. Lokhorst H.M. Kreuser E.D. Bloem A.C. Gunthert U. Eisterer W. 1996 Different CD44 splicing patterns define prognostic subgroups in multiple myeloma Blood 88 3101 3108
UKCCCR 1998 United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia 2nd edn British Journal of Cancer 77 1 10
Vacca A. Ria R. Semeraro F. Merchionne F. Coluccia M. Boccarelli A. Scavelli C. Nico B. Gernone A. Battelli F. Tabilio A. Guidolin D. Petrucci M.T. Ribatti D. Dammacco F. 2003 Endothelial cells in the bone marrow of patients with multiple myeloma Blood 102 3340 3348
Van Valckenborgh E. Bakkus M. Munaut C. Noel A. St Pierre Y. Asosingh K. Van Riet I. Van Camp B. Vanderkerken K. 2002 Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells International Journal of Cancer 101 512 518
Vande Broek I. Asosingh K. Allegaert V. Leleu X. Facon T. Vanderkerken K. Van Camp B. Van Riet I. 2004 Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor Leukemia 18 976 982
Vanderkerken K. De Raeve H. Goes E. Van Meirvenne S. Radl J. Van Riet I. Thielemans K. Van Camp B. 1997 Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse British Journal of Cancer 76 451 460
Weber G.F. 2001 The metastasis gene osteopontin: a candidate target for cancer therapy Biochimica et Biophysica Acta 1552 61 85
Weber G.F. Ashkar S. Glimcher M.J. Cantor H. 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1) Science 271 509 512
Wittig B.M. Johansson B. Zoller M. Schwarzler C. Gunthert U. 2000 Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7) Journal of Experimental Medicine 191 2053 2064
